Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Servier
Scientific Title
An International Phase Ib Multicentre Study to Characterize the Safety and Tolerability of Intravenously Administered S64315 a Selective Mcl-1 Inhibitor, in Combination With Orally Administered Venetoclax a Selective Bcl-2 Inhibitor in Patients With Acute Myeloid Leukaemia